The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Myc Roles in Hematopoiesis and Leukemia
Open accessAbstract
Hematopoiesis is a process capable of generating millions of cells every second, as distributed in many cell types. The process is regulated by a number of transcription factors that regulate the differentiation along the distinct lineages and dictate the genetic program that defines each mature phenotype. Myc was first discovered as the oncogene of avian leukemogenic retroviruses; it was later found translocated in human lymphoma. From then on, evidence accumulated showing that c-Myc is one of the transcription factors playing a major role in hematopoiesis. The study of genetically modified mice with overexpression or deletion of Myc has shown that c-Myc is required for the correct balance between self-renewal and differentiation of hematopoietic stem cells (HSCs). Enforced Myc expression in mice leads to reduced HSC pools owing to loss of self-renewal activity at the expense of increased proliferation of progenitor cells and differentiation. c-Myc deficiency consistently results in the accumulation of HSCs. Other models with conditional Myc deletion have demonstrated that different lineages of hematopoietic cells differ in their requirement for c-Myc to regulate their proliferation and differentiation. When transgenic mice overexpress c-Myc or N-Myc in mature cells from the lymphoid or myeloid lineages, the result is lymphoma or leukemia. In agreement, enforced expression of c-Myc blocks the differentiation in several leukemia-derived cell lines capable of differentiating in culture. Not surprising, MYC deregulation is recurrently found in many types of human lymphoma and leukemia. Whereas MYC is deregulated by translocation in Burkitt lymphoma and, less frequently, other types of lymphoma, MYC is frequently overexpressed in acute lymphoblastic and myeloid leukemia, through mechanisms unrelated to chromosomal translocation, and is often associated with disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Orkin, S. H., & Zon, L. I. (2008) · Cell · doi:10.1016/j.cell.2008.01.025 · Cited by 2,570
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Clonal selection and learning in the antibody system
Rajewsky, K. (1996) · Nature · doi:10.1038/381751a0 · Cited by 1,709
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., & Weissman, I. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141007 · Cited by 997
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Weng, A. P., Millholland, J. M., Yashiro-Ohtani, Y., Arcangeli, M. L., Lau, A., Wai, C., del Bianco, C., Rodriguez, C. G., Sai, H., Tobias, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1450406 · Cited by 870
Palomero, T., Lim, W. K., Odom, D. T., Sulis, M. L., Real, P. J., Margolin, A., Barnes, K. C., O'Neil, J., Neuberg, D., Weng, A. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606108103 · Cited by 826
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation
Wilson, A., Murphy, M. J., Oskarsson, T., Kaloulis, K., Bettess, M. D., Oser, G. M., Pasche, A.-C., Knabenhans, C., MacDonald, H. R., & Trumpp, A. (2004) · Genes & Development · doi:10.1101/gad.313104 · Cited by 823
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819
THE MOLECULAR GENETICS OF CELLULAR ONCOGENES
Varmus, H. E. (1984) · Annual Review of Genetics · doi:10.1146/annurev.ge.18.120184.003005 · Cited by 756
Molecular biology of bcr-abl1–positive chronic myeloid leukemia
Quintás-Cardama, A., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2008-03-144790 · Cited by 745
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Melo, J. V., & Barnes, D. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2147 · Cited by 623
The purification and characterization of fetal liver hematopoietic stem cells
Morrison, S. J., Hemmati, H. D., Wandycz, A. M., & Weissman, I. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10302 · Cited by 611
The Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R., & Bradley, A. (1993) · Genes & Development · doi:10.1101/gad.7.4.671 · Cited by 534
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression
Baudino, T. A., McKay, C., Pendeville-Samain, H., Nilsson, J. A., Maclean, K. H., White, E. L., Davis, A. C., Ihle, J. N., & Cleveland, J. L. (2002) · Genes & Development · doi:10.1101/gad.1024602 · Cited by 525
Coppola, J. A., & Cole, M. D. (1986) · Nature · doi:10.1038/320760a0 · Cited by 503
Dissecting p53 tumor suppressor functions in vivo
Schmitt, C. A., Fridman, J. S., Yang, M., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00047-8 · Cited by 485
Translocations involving c-myc and c-myc function
Boxer, L. M., & Dang, C. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204595 · Cited by 479
Gregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
The Pathogenesis of Burkitt's Lymphoma
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 466
Holt, J. T., Redner, R. L., & Nienhuis, A. W. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.963 · Cited by 464
Distinct Thresholds Govern Myc's Biological Output In Vivo
Murphy, D. J., Junttila, M. R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D. A., Brown-Swigart, L., Johnson, L., & Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.018 · Cited by 456
Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia
Johansson, B., Fioretos, T., & Mitelman, F. (2002) · Acta Haematologica · doi:10.1159/000046636 · Cited by 454
The hematopoietic stem cell in its place
Adams, G. B., & Scadden, D. T. (2006) · Nature Immunology · doi:10.1038/ni1331 · Cited by 454
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J. A., Cordon-Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
Gene expression profiling of pediatric acute myelogenous leukemia
Ross, M. E., Mahfouz, R., Onciu, M., Liu, H.-C., Zhou, X., Song, G., Shurtleff, S. A., Pounds, S., Cheng, C., Ma, J., et al. (2004) · Blood · doi:10.1182/blood-2004-03-1154 · Cited by 448
Salghetti, S. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.717 · Cited by 443
c-Myc regulates mammalian body size by controlling cell number but not cell size
Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G. R., & Bishop, J. M. (2001) · Nature · doi:10.1038/414768a · Cited by 439
The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice
Langdon, W. Y., Harris, A. W., Cory, S., & Adams, J. M. (1986) · Cell · doi:10.1016/0092-8674(86)90361-2 · Cited by 433
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia
Grabher, C., von Boehmer, H., & Look, A. T. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1880 · Cited by 425
Analysis of C-MYC Function in Normal Cells via Conditional Gene-Targeted Mutation
de Alboran, I. M., O'Hagan, R. C., Gärtner, F., Malynn, B., Davidson, L., Rickert, R., Rajewsky, K., DePinho, R. A., & Alt, F. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00088-7 · Cited by 398
Dominant negative MYC blocks transformation by ABL oncogenes
Sawyers, C. L., Callahan, W., & Witte, O. N. (1992) · Cell · doi:10.1016/0092-8674(92)90241-4 · Cited by 397
Myeloid Lineage Commitment from the Hematopoietic Stem Cell
Iwasaki, H., & Akashi, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.004 · Cited by 394
The Transcriptional Regulation of B Cell Lineage Commitment
Nutt, S. L., & Kee, B. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.010 · Cited by 387
Cell cycle deregulation in B-cell lymphomas
Sánchez-Beato, M., Sánchez-Aguilera, A., & Piris, M. A. (2003) · Blood · doi:10.1182/blood-2002-07-2009 · Cited by 358
Shou, Y., Martelli, M. L., Gabrea, A., Qi, Y., Brents, L. A., Roschke, A., Dewald, G., Kirsch, I. R., Bergsagel, P. L., & Kuehl, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.228 · Cited by 347
Shizuru, J. A., Negrin, R. S., & Weissman, I. L. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152334 · Cited by 339
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation
Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A., & Alt, F. W. (2000) · Genes & Development · doi:10.1101/gad.14.11.1390 · Cited by 335
Wu, S., Cetinkaya, C., Munoz-Alonso, M. J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, J., & Larsson, L.-G. (2003) · Oncogene · doi:10.1038/sj.onc.1206145 · Cited by 317
Self-citationHematopoietic stem cell function and survival depend on c-Myc and N-Myc activity
Laurenti, E., Varnum-Finney, B., Wilson, A., Ferrero, I., Blanco-Bose, W. E., Ehninger, A., Knoepfler, P. S., Cheng, P.-F., MacDonald, H. R., Eisenman, R. N., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.005 · Cited by 305
Müller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B., Köhler, G., Stelljes, M., Puccetti, E., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2890-2904.2004 · Cited by 303
Dmitrovsky, E., Kuehl, W. M., Hollis, G. F., Kirsch, I. R., Bender, T. P., & Segal, S. (1986) · Nature · doi:10.1038/322748a0 · Cited by 302
Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation
Prochownik, E. V., & Kukowska, J. (1986) · Nature · doi:10.1038/322848a0 · Cited by 299
Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal
Zon, L. I. (2008) · Nature · doi:10.1038/nature07038 · Cited by 296
Adult acute lymphoblastic leukemia: Concepts and strategies
Faderl, S., O'Brien, S., Pui, C., Stock, W., Wetzler, M., Hoelzer, D., & Kantarjian, H. M. (2010) · Cancer · doi:10.1002/cncr.24862 · Cited by 289
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
Avet-Loiseau, H., Gerson, F., Magrangeas, F., Minvielle, S., Harousseau, J.-L., & Bataille, R. (2001) · Blood · doi:10.1182/blood.v98.10.3082 · Cited by 289
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 286
Sheiness, D., & Bishop, J. M. (1979) · Journal of Virology · doi:10.1128/jvi.31.2.514-521.1979 · Cited by 274
c-Myc Is a Critical Target for C/EBPα in Granulopoiesis
Johansen, L. M., Iwama, A., Lodie, T. A., Sasaki, K., Felsher, D. W., Golub, T. R., & Tenen, D. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3789-3806.2001 · Cited by 263
MOLECULAR GENETICS OF T CELL DEVELOPMENT
Rothenberg, E. V., & Taghon, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115737 · Cited by 261
Huang, M.-J., Cheng, Y.-C., Liu, C.-R., Lin, S., & Liu, H. E. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.06.019 · Cited by 259
Erythropoiesis: Model systems, molecular regulators, and developmental programs
Tsiftsoglou, A. S., Vizirianakis, I. S., & Strouboulis, J. (2009) · IUBMB Life · doi:10.1002/iub.226 · Cited by 199
Identification of genes with abnormal expression changes in acute myeloid leukemia
Stirewalt, D. L., Meshinchi, S., Kopecky, K. J., Fan, W., Pogosova‐Agadjanyan, E. L., Engel, J. H., Cronk, M. R., Dorcy, K. S., McQuary, A. R., Hockenbery, D., et al. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20500 · Cited by 191
Matsuoka, S., Oike, Y., Onoyama, I., Iwama, A., Arai, F., Takubo, K., Mashimo, Y., Oguro, H., Nitta, E., Ito, K., et al. (2008) · Genes & Development · doi:10.1101/gad.1621808 · Cited by 185
Differential Complementation of Bcr-Abl Point Mutants with c-Myc
Afar, D. E. H., Goga, A., McLaughlin, J., Witte, O. N., & Sawyers, C. L. (1994) · Science · doi:10.1126/science.8153630 · Cited by 184
Luo, H., Li, Q., O'Neal, J., Kreisel, F., Le Beau, M. M., & Tomasson, M. H. (2005) · Blood · doi:10.1182/blood-2005-02-0734 · Cited by 176
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
Lugo, T. G., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1263 · Cited by 172
Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells
Satoh, Y., Matsumura, I., Tanaka, H., Ezoe, S., Sugahara, H., Mizuki, M., Shibayama, H., Ishiko, E., Ishiko, J., Nakajima, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400407200 · Cited by 159
Jak2 is involved in c-Myc induction by Bcr-Abl
Xie, S., Lin, H., Sun, T., & Arlinghaus, R. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205942 · Cited by 156
Diaz-Blanco, E., Bruns, I., Neumann, F., Fischer, J. C., Graef, T., Rosskopf, M., Brors, B., Pechtel, S., Bork, S., Koch, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404549 · Cited by 148
Storlazzi, C. T., Fioretos, T., Surace, C., Lonoce, A., Mastrorilli, A., Strömbeck, B., D’Addabbo, P., Iacovelli, F., Minervini, C. F., Aventin, A. M., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl010 · Cited by 148
Qian, Z., Fernald, A. A., Godley, L. A., Larson, R. A., & Beau, M. M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222491799 · Cited by 141
Hematopoietic developmental pathways: on cellular basis
Iwasaki, H., & Akashi, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210754 · Cited by 141
Transcriptional control of erythropoiesis: emerging mechanisms and principles
Kim, S.-I., & Bresnick, E. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210761 · Cited by 134
Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase–substrate complex
Reavie, L. B., Gatta, G. D., Moran-Crusio, K., Aranda-Orgillés, B., Buckley, S. M., Thompson, B. J., Lee, E., Gao, J., Bredemeyer, A. L., Helmink, B. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1839 · Cited by 129
Huang, C., Bredemeyer, A. L., Walker, L. M., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737972 · Cited by 125
c-Myc mediates pre-TCR-induced proliferation but not developmental progression
Dose, M., Khan, I., Guo, Z., Kovalovsky, D., Krueger, A., von Boehmer, H., Khazaie, K., & Gounari, F. (2006) · Blood · doi:10.1182/blood-2006-02-005900 · Cited by 124
Watanabe, S., Itoh, T., & Arai, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12681 · Cited by 121
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia
Gutiérrez, A., Sanda, T., Ma, W., Zhang, J., Grebliunaite, R., Dahlberg, S. E., Neuberg, D. S., Protopopov, A. I., Winter, S. S., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-234377 · Cited by 120
Schmidt, E. V., Pattengale, P. K., Weir, L., & Leder, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6047 · Cited by 116
Myc stimulates B lymphocyte differentiation and amplifies calcium signaling
Habib, T., Park, H., Tsang, M., de Alborán, I. M., Nicks, A., Wilson, L., Knoepfler, P. S., Andrews, S. F., Rawlings, D. J., Eisenman, R. N., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704173 · Cited by 115
Chronic myelogenous leukemia molecular signature
Nowicki, M. O., Pawlowski, P., Fischer, T. H., Heß, G., Pawlowski, T., & Skórski, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206620 · Cited by 114
Walkley, C. R., Fero, M. L., Chien, W., Purton, L. E., & McArthur, G. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1214 · Cited by 114
Multiple mechanisms regulate c‐myc gene expression during normal T cell activation.
Lindsten, T., June, C. H., & Thompson, C. B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03133.x · Cited by 113
MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
Beverly, L. J., & VARMUS, H. E. (2009) · Oncogene · doi:10.1038/onc.2008.466 · Cited by 113
Insertion of c- Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice
Park, S. S., Kim, J. S., Tessarollo, L., Owens, J. D., Peng, L., Han, S. S., Chung, S. T., Torrey, T. A., Cheung, W. C., Polakiewicz, R. D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0268 · Cited by 112
Dose, M., Sleckman, B. P., Han, J., Bredemeyer, A. L., Bendelac, A. S., & Gounari, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812255106 · Cited by 110
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
Malempati, S., Tibbitts, D., Cunningham, M., Akkari, Y. M. N., Olson, S. B., Fan, G., & Sears, R. C. (2006) · Leukemia · doi:10.1038/sj.leu.2404317 · Cited by 102
Myc translocations in B cell and plasma cell neoplasms
Janz, S. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.017 · Cited by 101
Defining the specific physiological requirements for c-Myc in T cell development
Douglas, N. C., Jacobs, H. C., Bothwell, A. L. M., & Hayday, A. (2001) · Nature Immunology · doi:10.1038/86308 · Cited by 99
Larsson, L. G., Ivhed, I., Gidlund, M., Pettersson, U., Vennström, B., & Nilsson, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2638 · Cited by 96
Dubois, N. C., Adolphe, C., Ehninger, A., Wang, R. A., Robertson, E. J., & Trumpp, A. (2008) · Development · doi:10.1242/dev.022707 · Cited by 96
Selective Requirement for c-Myc at an Early Stage of Vα14i NKT Cell Development
Mycko, M. P., Ferrero, I., Wilson, A., Jiang, W., Bianchi, T., Trumpp, A., & MacDonald, H. R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803394 · Cited by 95
Chronic Lymphocytic Leukemia: Diagnosis and Treatment
Strati, P., Jain, N., & O'Brien, S. M. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.03.002 · Cited by 92
Refaeli, Y., Young, R. M., Turner, B. C., Duda, J., Field, K. A., & Bishop, J. M. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060152 · Cited by 92
c-Myc–mediated control of cell fate in megakaryocyte-erythrocyte progenitors
Guo, Y., Niu, C. S., Breslin, P., Tang, M., Zhang, S., Wei, W., Kini, A. R., Paner, G. P., Alkan, S., Morris, S. W., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197947 · Cited by 90
Klemsz, M. J., Justement, L. B., Palmer, E., & Cambier, J. C. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.3.1032 · Cited by 88
Larramendy, M. L., Niini, T., Elonen, E., Nagy, B., Ollila, J., Vihinen, M., & Knuutila, S. (2002) · PubMed · Cited by 84
Expression and function of myc family genes.
Zimmerman, K., & Alt, F. W. (1990) · PubMed · Cited by 82
Palomero, T., & Ferrando, A. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4864 · Cited by 81
Huh, Y. O., Lin, K. I., Vega, F., Schlette, E. J., Yin, C. C., Keating, M. J., Luthra, R., Medeiros, L. J., & Abruzzo, L. V. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07152.x · Cited by 80
Niu, C. S., Zhang, J., Breslin, P., Onciu, M. M., Ma, Z., & Morris, S. W. (2009) · Blood · doi:10.1182/blood-2009-01-197921 · Cited by 77
c-mycin the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo
He, C., Hu, H., Braren, R., Fong, S.-Y., Trumpp, A., Carlson, T. R., & Wang, R. A. (2008) · Development · doi:10.1242/dev.020131 · Cited by 76
Altered expression of G1-specific genes in human malignant myeloid cells.
Calabretta, B., Venturelli, D., Kaczmarek, L., et al. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1495 · Cited by 74
Frequent upregulation of MYC in plasma cell leukemia
Chiecchio, L., Dagrada, G. P., White, H. E., Towsend, M. R., Protheroe, R. K. M., Cheung, K. L., Stockley, D. M., Orchard, K. H., Cross, N. C. P., Harrison, C. J., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20670 · Cited by 74
Overexpression of N-Myc Rapidly Causes Acute Myeloid Leukemia in Mice
Kawagoe, H., Kandilci, A., Kranenburg, T. A., & Grosveld, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1118 · Cited by 72
MYC levels govern hematopoietic tumor type and latency in transgenic mice
Smith, D. P., Bath, M. L., Metcalf, D., Harris, A. W., & Cory, S. (2006) · Blood · doi:10.1182/blood-2006-01-0172 · Cited by 71
Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis?
León, J., Ferrándiz, N., Acosta, J. C., & Delgado, M. D. (2009) · Cell Cycle · doi:10.4161/cc.8.8.8126 · Cited by 69
Self-citationDelgado, M. D., Lerga, A., Cañelles, M., et al. (1995) · PubMed · doi:10.5281/zenodo.18338787 · Cited by 68
Self-citationThe Notch1/c-Myc Pathway in T Cell Leukemia
Sharma, V. M., Draheim, K., & Kelliher, M. A. (2007) · Cell Cycle · doi:10.4161/cc.6.8.4134 · Cited by 63
Yu, D., Allman, D. A., Goldschmidt, M. H., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1797 · Cited by 63
Acosta, J. C., Ferrándiz, N., Bretones, G., Torrano, V., Blanco, R. E., Richard, C., O’Connell, B. C., Sedivy, J. M., Delgado, M. D., & León, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00752-08 · Cited by 58
Self-citationCañelles, M., Delgado, M. D., Hyland, K. M., Lerga, A., Richard, C., Dang, C. V., & León, J. (1997) · Oncogene · doi:10.1038/sj.onc.1200948 · Cited by 58
Self-citationRice, K. L., Hormaeche, I., Doulatov, S. R., Flatow, J. M., Grimwade, D. J., Mills, K., Leiva, M., Ablain, J., Ambardekar, C., McConnell, M. J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-206524 · Cited by 56
Thompson, A., Zhang, Y., Kamen, D. M., Jackson, C. W., Cardiff, R. D., & Ravid, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.22976 · Cited by 55
Yu, D., & Thomas‐Tikhonenko, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205244 · Cited by 52
Baena, E., Ortiz, M., Martínez‐A, C., & de Alborán, I. M. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.05.015 · Cited by 51
Handa, H., Hegde, U. P., Kotelnikov, V. M., et al. (1997) · Leukemia Research · doi:10.1016/s0145-2126(97)00006-4 · Cited by 49
Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression
Brazma, D., Grace, C. D., Howard‐Reeves, J., Melo, J. V., Holyoke, T., Apperley, J. F., & Nacheva, E. P. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20487 · Cited by 48
The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis
Cardone, M., Kandilci, A., Carella, C., Nilsson, J. A., Brennan, J. A., Ekmekçi, S. S., Özbek, U., Boyd, K. L., Cleveland, J. L., & Grosveld, G. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2395-2405.2005 · Cited by 45
Bazarov, A., Adachi, S., Li, S. F., Mateyak, M. K., Wei, S., & Sedivy, J. M. (2001) · PubMed · Cited by 44
Smith, D. P., Bath, M. L., Harris, A. W., & Cory, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208399 · Cited by 43
Wilda, M., Busch, K., Klose, I., Keller, T., Woessmann, W., Kreuder, J. G., Harbott, J., & Borkhardt, A. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20063 · Cited by 42
Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation
Shafarenko, M., Liebermann, D. A., & Hoffman‐Liebermann, B. (2005) · Blood · doi:10.1182/blood-2004-08-3056 · Cited by 34
Transcriptional regulatory networks in haematopoiesis
Miranda‐Saavedra, D., & Göttgens, B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.09.001 · Cited by 31
c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma
Scheller, H. V., Tobollik, S., Kutzera, A., Eder, M. D., Unterlehberg, J., Pfeil, I., & Jungnickel, B. (2009) · Oncogene · doi:10.1038/onc.2009.377 · Cited by 31
Palomo, C., Zou, X., Nicholson, I., Bützler, C., & Brüggemann, M. (1999) · PubMed · Cited by 30
Skoda, R. C., Tsai, S., Orkin, S. H., & Leder, P. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1603 · Cited by 30
Court, E. L., Smith, M. A., Avent, N. D., Hancock, J. T., Morgan, L. M., Gray, A., & Smith, J. G. (2004) · Leukemia Research · doi:10.1016/s0145-2126(03)00406-5 · Cited by 29
Hirouchi, T., Takabatake, T., Yoshida, K., Nitta, Y., Nakamura, M. M., Tanaka, S., Ichinohe, K., Oghiso, Y., & Tanaka, K. J. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.01.015 · Cited by 28
Lerga, A., Crespo, P., Berciano, M. T., Delgado, M. D., Cañelles, M., Calés, C., Richard, C., Ceballos, E., Gutiérrez, P., Ajenjo, N., et al. (1999) · PubMed · Cited by 27
Self-citationBeck, Z., Bácsi, A., Kovács, E. M., KISS, J., Kiss, A., Balogh, E., Telek, B., th, F. D. T., Andirkócute, I., Oláh, É., et al. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057542 · Cited by 24
Gómez‐Casares, M. T., Delgado, M. D., Lerga, A., et al. (1993) · PubMed · doi:10.5281/zenodo.18338170 · Cited by 22
Self-citationAmifostine impairs p53-mediated apoptosis of human myeloid leukemia cells.
Acosta, J. C., Richard, C., Delgado, M. D., Horita, M., Rizzo, M. G., Fernández-Luna, J. L., & León, J. (2003) · PubMed · Cited by 21
Self-citationC-myc expression in cell lines derived from chronic myeloid leukemia.
Gómez‐Casares, M. T., Vaque, J. P., Lemes, A., Molero, T., Delgado, M. D., & León, J. (2004) · PubMed · Cited by 20
Self-citationTheophile, K., Buesche, G., Kreipe, H. H., & Bock, O. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0424-1 · Cited by 10
Mutational analysis of MYC in common epithelial cancers and acute leukemias
Lee, J. W., Soung, Y. H., Kim, S. Y., Nam, S. W., Park, W. S., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_383.x · Cited by 9
Cited by
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Yankova, E., Blackaby, W., Albertella, M., Rak, J., De Braekeleer, E., Tsagkogeorga, G., Pilka, E. S., Aspris, D., Leggate, D., Hendrick, A. G., et al. (2021) · Nature · doi:10.1038/s41586-021-03536-w · Cited by 1,352
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.016 · Cited by 968
RNA N6-methyladenosine modification in cancers: current status and perspectives
Deng, X., Su, R., Weng, H., Huang, H., Li, Z., & Chen, J. (2018) · Cell Research · doi:10.1038/s41422-018-0034-6 · Cited by 845
Bretones, G., Delgado, M. D., & León, J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.013 · Cited by 747
Self-citationA Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
Bahr, C., von Paleske, L., Uslu, V. V., Remeseiro, S., Takayama, N., Ng, S. W., Murison, A., Langenfeld, K., Petretich, M., Scognamiglio, R., et al. (2018) · Nature · doi:10.1038/nature25193 · Cited by 328
Metadata
- Authors
- Delgado, M. D., & Leon, J.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2010-06-01
- Volume
- 1
- Issue
- 6
- Pages
- 605-616
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2144965236
- Cited by
- 255
- References
- 130
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.